胰腺癌胰切除术前后的胃肠道症状与健康相关生活质量:GO-PANC纵向全国研究
该全国性队列研究纳入1009例胰腺癌胰切除患者,术前95%存在胃肠道症状,症状评分在术后0-3个月达峰、9-12个月回落至术前或更低水平;严重症状从术前61%降至术后9-12个月52%,≥2个严重症状者HRQoL临床相关下降10-20分至>20分。
要点
- 胰腺癌胰切除患者术前胃肠道症状普遍,以胀气、口干、味觉异常和排便习惯改变常见。
- 胃肠道症状评分在术后0-3个月达峰,9-12个月多恢复至术前或更低水平。
- 术后9-12个月仍有52%患者存在严重胃肠道症状,且与HRQoL显著下降相关。
核心结论
- 胰腺癌胰切除患者胃肠道症状高度普遍,术后3个月内达峰,严重症状影响超过半数术后患者并导致HRQoL显著下降。
研究设计与样本
- 荷兰胰腺癌项目前瞻性队列研究,纳入1009例胰腺癌胰切除患者,完成2995份问卷,术前及术后0-3、3-6、6-9、9-12个月评估胃肠道症状与HRQoL,采用多变量广义线性混合模型分析。
主要发现
- 术前95%患者存在胃肠道症状,常见胀气、口干、味觉问题和排便习惯改变。
- 胃肠道症状评分在术后0-3个月达峰,9-12个月一般回落至术前或更低水平。
- 严重胃肠道症状(定义为「相当多」或「非常多」)从术前61%降至术后9-12个月52%。
- 存在≥2个严重症状的患者HRQoL评分出现10-20分(中等)至>20分(较大)的临床相关下降。
关键数值与推荐
- 严重胃肠道症状定义为「相当多」或「非常多」。
- HRQoL临床相关下降定义为10-20分(中等)至>20分(较大)。
临床怎么用
- 胰腺癌胰切除患者术前即应评估胃肠道症状,术后3个月内重点监测并干预严重症状以减轻HRQoL下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing pancreatectomy for pancreatic cancer may experience gastrointestinal symptoms that impair health-related quality of life (HRQoL) before and after pancreatic surgery. The longitudinal course of these symptoms and their association with HRQoL remains unclear as large prospective studies are lacking. METHODS: Patients who underwent pancreatectomy for pancreatic cancer and filled out questionnaires of the Dutch Pancreatic Cancer Project were included in this cohort study. Gastrointestinal symptoms and HRQoL were assessed before surgery and 0-3, 3-6, 6-9, and 9-12 months after surgery. Multivariable generalized linear mixed models were applied to evaluate longitudinal changes in gastrointestinal symptoms and their association with HRQoL. RESULTS: After pancreatectomy for pancreatic cancer, overall, 1009 patients were included and 2995 questionnaires were completed. Before surgery, gastrointestinal symptoms were present in 95% of patients; commonly flatulence, dry mouth, problems with taste, and altered bowel habits. Gastrointestinal symptom scores peaked at 0-3 months after surgery and generally returned to preoperative or lower levels at 9-12 months after surgery. Severe gastrointestinal symptoms (defined as 'quite a bit' or 'very much') decreased from 61% of patients before surgery to 52% at 9-12 months after surgery. Patients with two or more severe symptoms had moderate (10-20 points) to large (>20 points) clinically relevant lower scores for HRQoL. CONCLUSION: Gastrointestinal symptoms in patients undergoing pancreatectomy for pancreatic cancer were highly prevalent and peaked within 3 months after surgery. Severe gastrointestinal symptoms affected more than half of all patients after surgery, which led to substantial declines in HRQoL.
引用
- Vissers PAJ, Schoorlemmer A, Pek CJ, et al. Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study. Br J Surg. 2026. PMID: 42837495. doi:10.1093/bjs/znag122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。